Biotech · Private company · Durham, NC, US
Chimerix Inc
SEC CIK 0001117480
Track this companyFree. Adds Chimerix Inc to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaPHASE2 · RECRUITING · started Jul 16, 2026ClinicalTrials.gov NCT07533942 · fetched Nov 12, 2026
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)PHASE3 · RECRUITING · started Jan 23, 2023ClinicalTrials.gov NCT05580562 · fetched Nov 12, 2026
SEC filings10
- 8-K · 8-KSEC EDGAR · filed Apr 21, 2025 · fetched Nov 12, 2026
- 10-K/A · FORM 10-K/ASEC EDGAR · filed Apr 16, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 21, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 21, 2025 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed Mar 5, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 5, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 3, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 30, 2024 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 10, 2024 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 14, 2024 · fetched Nov 12, 2026